![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
01 Naprod Life Sciences (1)
02 Accure Labs (1)
03 Jodas Expoim Pvt. Ltd (1)
04 Natco Pharma (1)
05 Novartis Pharmaceuticals Australia Pty Limited (2)
06 Novartis Pharmaceuticals Corporation (2)
07 Novartis South Africa (Pty) Ltd (1)
08 TherDose Pharma (1)
09 Blank (6)
01 Antic-calc Tablet (2)
02 FCT (1)
03 Lapatinib 250Mg 70 Units' Oral Use (1)
04 Lapatinib 250Mg 84 Combined Oral Use (1)
05 TABLET (2)
06 TABLET;ORAL (2)
07 Tablet (3)
08 Tablets (2)
09 Blank (2)
01 Generic (2)
02 Originator (1)
03 Prescription (1)
04 RX (2)
05 Blank (10)
01 LAPATINIB DITOSYLATE (1)
02 LAPATITHER (1)
03 TYKERB (2)
04 Tykerb (3)
05 Tyverb (4)
06 Blank (5)
01 Australia (2)
02 Canada (1)
03 India (4)
04 Italy (2)
05 Norway (2)
06 South Africa (1)
07 Switzerland (2)
08 USA (2)